beclometasone dipropionate aqueous nasal spray, 50 micrograms per spray
generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - beclometasone dipropionate - nasal spray, solution - beclometasone dipropionate 50 µg - nasal preparations
pulvinal beclometasone dipropionate 100micrograms/dose dry powder inhaler
chiesi ltd - beclometasone dipropionate - inhalation powder - 100microgram/1dose
pulvinal beclometasone dipropionate 200micrograms/dose dry powder inhaler
chiesi ltd - beclometasone dipropionate - inhalation powder - 200microgram/1dose
pulvinal beclometasone dipropionate 400micrograms/dose dry powder inhaler
chiesi ltd - beclometasone dipropionate - inhalation powder - 400microgram/1dose
beconase allergy & hayfever beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle
viatris pty ltd - beclometasone dipropionate, quantity: 500 microgram/g - spray, nasal - excipient ingredients: polysorbate 80; dispersible cellulose; hydrochloric acid; glucose; purified water; benzalkonium chloride; phenethyl alcohol - for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years and over.
fostair 100/6 beclometasone dipropionate 100 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
chiesi australia pty ltd - beclometasone dipropionate, quantity: 100 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches). copd (fostair 100/6 only) symptomatic treatment of adults with severe copd (fev1 less than 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
fostair 200/6 beclometasone dipropionate 200 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
chiesi australia pty ltd - beclometasone dipropionate, quantity: 200 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches).
qvar 100 autohaler beclometasone dipropionate 100mcg per actuation pressurised inhalation
inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - qvar is indicated for the prophylactic management of asthma.
qvar 100 inhaler beclometasone dipropionate 100mcg per actuation pressurised inhalation
inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - prophylactic management of asthma.
qvar 50 inhaler beclometasone dipropionate 50mcg per actuation pressurised inhalation
inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.05 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - for the prophylactic management of asthma.